Synthesis and structural characterization of neutral higher-coordinate silicon(IV) complexes with tridentate dianionic chelate ligands

The neutral pentacoordinate silicon(IV) complexes 8 and 9 with an SiO2N3 skeleton and the neutral hexacoordinate silicon(IV) complex 10.1/2 CH3CN with an SiO4N2 skeleton were synthesized, starting from tetra(cyanato-N)silane or tetra(thiocyanato-N)silane. Compounds 8 and 9 contain one tridentate dianionic ligand derived from 4-[(2-hydroxyphenyl)amino]pent-3-en-2-one and two monodentate singly charged cyanato-N or thiocyanato-N ligands bound to the silicon(IV) coordination center, whereas the silicon(IV) center of 10 is coordinated by two of these tridentate dianionic ligands. All compounds were characterized by single-crystal X-ray diffraction and solid-state and solution NMR spectroscopy. To get more information about the stereochemistry of the compounds studied, the experimental investigations were complemented by computational studies.     

Hydride and dihydrogen dicarbonylrhenium(I) complexes with phosphites, phosphonites and phosphinites

Photoirradiation of a toluene solution of [ReH(CO)₃(L)] [S. Bolaño, J. Bravo, R. Carballo, S. García-Fontán, U. Abram, E.M. Vázquez-López, Polyhedron 18 (1999) 1431-1436] [L = 1,2-bis(diphenylphosphinoxy)ethane] in the presence of PPh_n(OR)_3−n (n = 0, 1; R = Me, Et) leads to the replacement of a CO ligand by the corresponding monodentate phosphite or phosphonite ligand to give new hydride compounds of formula [ReH(CO)₂(L)(L′)] [L′ = P(OMe)₃ (1); P(OEt)₃ (2); PPh(OMe)₂ (3); PPh(OEt)₂ (4)]. Protonation of compounds 1-4 in CD₂Cl₂, with HBF₄.OMe₂ or with HOOCCF₃ at 193 K in a NMR tube, gave the corresponding dihydrogen complexes. When the temperature was increased from 193 to 293 K, the η²-H₂ ligand was replaced by OMe₂ or ⁻OOCCF₃ groups (depending on the acid employed) to give new stable complexes and the loss of H₂ gas.     

Synthesis and Structural Characterization of Novel Neutral Higher‐Coordinate Silicon(IV) Complexes with SiON3C and SiON4C Skeletons

The neutral pentacoordinate silicon(IV) complex 10 (SiON₃C skeleton) and the neutral hexacoordinate silicon(IV) complex 11 (SiON₄C skeleton) were synthesized, starting from methyldi(thiocyanato‐N)silane ( 7 ). In addition to their monodentate thiocyanato‐N and methyl ligands, these compounds contain a tridentate dianionic O,N,N ligand ( 10 ) or a tridentate monoanionic O,N,N ligand ( 11 ). Compounds 10 and 11 were characterized by single‐crystal X‐ray diffraction and solid‐state and solution NMR spectroscopy. According to these studies, compounds 10 and 11 exist in solution as well.     

Bis[N,N'-diisopropylbenzamidinato(-)]silicon(II): a silicon(II) compound with both a bidentate and a monodentate amidinato ligand

Well looked-after: reductive HCl elimination of the λ(6)-silicon(IV) complex 1 leads to the λ(3)-silicon(II) species 2, a novel type of donor-stabilized silylene. Reaction of 2 with [W(CO)(6)] and with I(2) yields the λ(5)-silicon(II) complex 3 and the λ(6)-silicon(IV) complex 4, respectively.     

4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B

The multi-target-directed ligands (MTDLs) strategy is encouraged for the development of novel modulators targeting multiple pathways in the neurodegenerative cascade typical for Alzheimer’s disease (AD). Based on the structure of an in-house irreversible monoamine oxidase B (MAO-B) inhibitor, we aimed to introduce a carbamate moiety on the aromatic ring to impart cholinesterase (ChE) inhibition, and to furnish multifunctional ligands targeting two enzymes that are intricately involved in AD pathobiology. In this study, we synthesized three dual hMAO-B/hBChE inhibitors 13–15, with compound 15 exhibiting balanced, low micromolar inhibition of hMAO-B (IC₅₀ of 4.3 µM) and hBChE (IC₅₀ of 8.5 µM). The docking studies and time-dependent inhibition of hBChE confirmed the initial expectation that the introduced carbamate moiety is responsible for covalent inhibition. Therefore, dual-acting compound 15 represents an excellent starting point for further optimization of balanced MTDLs     

Extending the Substrate Scope for the Asymmetric Iridium‐Catalyzed Hydrogenation of Minimally Functionalized Olefins by Using Biaryl Phosphite‐Based Modular Ligand Libraries

Asymmetric hydrogenation is one of the most efficient and atom‐economical tools to prepare chiral molecules. However, the enantiodiscrimination of simple, minimally functionalized olefins is still challenging and requires more sophisticated ligand design. Herein, we discuss our progress in the successful development of ligand design for the iridium‐catalyzed asymmetric hydrogenation of minimally functionalized olefins.

     

Combining [Arene–Ru] with Azocarboxamide to Generate a Complex with Cytotoxic Properties

Azocarboxamide (azcH) has been combined for the first time with [Ru–Cym] to generate metal complexes with N,N‐ and N,O‐coordination mode, [(Cym)Ru(azc)Cl] and [(Cym)Ru(azcH)Cl]⁺[PF₆]^?. Geometric and electronic structures of the complexes are reported along with their in vitro activities against different tumour cell lines and preliminary results on solution chemistry. Compound [(Cym)Ru(azc)Cl] exhibited remarkable cytotoxic properties. It was cell‐type specific and had comparable IC₅₀ values towards both cancer cells and their drug‐resistant subline. A tenfold increase in the sensitivity towards [(Cym)Ru(azc)Cl] was noted for the tumour cells with depleted intracellular glutathione (GSH) level, suggesting the essential role of GSH in cell response to this compound.     

Synthesis,crystal structure and reactivity of a new pentacoordinated chiral dioxomolybdenum(VI) complex

The novel tridentate chiral ligand 2,6-bis{[(1R,2S,4R)-2-hydroxy-1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl]}pyridine (1) was readily prepared by reaction of 2,6-dilithiopyridine with (R)-(−)-fenchone. Reaction of 1 with [MoO₂(acac)₂] resulted in the formation of the new metal-oxo five-coordinated complex [MoO₂(ONO)] (2) [ONO = (1 – 2H)]. The reactivity of 2 has been studied and the derivatives [MoS₂(ONO)] (3) and [MoO(O₂)(ONO)] (4) were prepared. The compounds 1–4 have been characterised by ¹H and ¹³C{¹H} NMR, microanalysis and IR spectroscopy. Furthermore, the molecular structures of 1 and 2 have been determined by single-crystal X-ray diffraction. The behaviour of 2 as catalyst in oxotransfer and in nucleophilic substitution of propargylic alcohols reactions has been tested.     

Synthesis and structure of new palladium complexes with the ligand 2-(diphenylphosphino)-1-methylimidazole: Evidence of hemilability

Several Pd(II) complexes containing the potentially bidentate ligand 2-(diphenylphosphino)-1-methylimidazole, dpim, have been synthesized and characterized: [PdCl₂(dpim)]_n (1), [PdCl₂(H₂O)(dpim-κP)] (2), [PdClMe(μ-dpim-κP,κN)]₂ (3) (previously described), [PdClMe(dpim-κP)₂] (4), [Pd(C₆F₅)₂(dpim-κP)₂] (5) and [Pd(η³-2-Me-C₃H₄)(μ-dpim-κP,κN)]₂[PF₆]₂ (6). The highly insoluble complex 1 dissolves in wet DMSO-d₆ to give the water adduct 2 in which a hydrogen bond is established between one of the water hydrogens and the imidazolyl nitrogen. Two types of coordination mode have been found for the dpim ligand in these derivatives, with the ligand behaving as P monodentate and also as a P,N bridge. The transformations between 3 and 4 demonstrate the hemilability of the dpim ligand. Complex 6 was obtained as a mixture of two pairs of enantiomers (R,S)/(S,R) and (R,R)/(S,S). Analysis of the fluxional behaviour of 6, in which the allyl group acts as a “reporter ligand”, indicates that Pd-N bond rupture takes place - again providing evidence of the hemilabile character of the dpim ligand.     

Synthesis, structure and electrochemistry of cationic diruthenium complexes of the type [(N∩N)2Ru2(CO)2(μ-CO)2(μ-OOCFc)] containing a ferrocenecarboxylato bridge and two chelating aromatic diimine ligands

The dinuclear bis(ferrocenecarboxylato) complex Ru₂(CO)₄(μ-OOCFc)₂(py)₂ (Fc = ferrocenyl, py = pyridine) was found to react with aromatic diimines (2,2′-dipyridyl, 4,4′-dimethyl-2,2′-dipyridyl, 1,10-phenanthroline, 5-nitro-1,10-phenanthroline, and 5-amino-1,10-phenanthroline) in methanol to give the cationic diruthenium complexes [(N∩N)₂Ru₂(CO)₂(μ-CO)₂(μ-OOCFc)]⁺ (1: N∩N = 2,2′-dipyridyl, 2: N∩N = 4,4′-dimethyl-2,2′-dipyridyl, 3: N∩N = 1,10-phenanthroline, 4: N∩N = 5-nitro-1,10-phenanthroline, 5: N∩N = 5-amino-1,10-phenanthroline), which have been isolated as the hexafluorophosphate salts. The molecular structure of 3, solved by single-crystal X-ray analysis of the tetraphenylborate salt [3][BPh₄], shows a diruthenium backbone bridged by two carbonyl and by one ferrocenecarboxylato ligand, the two 1,10-phenanthroline ligands being in the axial positions. Cyclic voltammetry in dichloromethane reveals for all compounds two successive oxidations due to ferrocene/ferrocenium redox couple and oxidation of the diruthenium core.     

Dichroic, dinuclear mu2-(eta2-NO)-nitrosoaniline-bridged complexes of rhenium of the type [[(CO)3Re(mu-X)]2ONC6H4NR2] (X = Cl, Br, I; R = Me, Et)

A series of unusual dinuclear mu2-(eta2-NO)-nitrosoaniline-bridged complexes [[(CO)3Re(mu-X)]2ONC6H4NR2] (X = Cl, Br, I; R = Me, Et) with dichroic properties have been synthesised by reaction of pentacarbonylhalogenorhenium(I) [(CO)5ReX] (X = Cl, Br, I) with the corresponding nitrosoaniline derivatives R2NC6H4NO (R = Me, Et). The deeply coloured solutions in CH2Cl2 show broad UV/Vis absorptions from 595 to 620 nm depending on the halogen bridges and N substituents. Single crystals of all six compounds exhibit a pronounced linear dichroism. The molecular structures have been determined by single-crystal X-ray analyses. All the compounds contain two face-shared octahedra, with two halogens and one NO ligand as bridges. The NO ligand coordinates in a nonsymmetrical eta2-like fashion with N or O coordination to each Re centre. Therefore, the C-nitroso group and the planar NC2 moiety of NR2 both lie almost exactly within the symmetry plane of the dinuclear complexes. These complexes belong to the novel and simple class of neutral dinuclear C-nitroso complexes that include the rare, non-assisted mu2-(eta2-NO) ligand function and have only single halogen atoms in bridging positions.     

Triphenylantimony(v) catecholates and o-amidophenolates: reversible binding of molecular oxygen

Novel neutral antimony(V) complexes were isolated as crystalline materials and characterized by IR and NMR spectroscopy: o-amidophenolate complexes [4,6-di-tert-butyl-N-(2,6-dimethylphenyl)-o-amidophenolato]triphenylantimony(V) (Ph3Sb[AP-Me], 1) and [4,6-di-tert-butyl-N-(2,6-diisopropylphenyl)-o-amidophenolato]triphenylantimony(v) (Ph3Sb[AP-iPr], 2); catecholate complexes (3,6-di-tert-butyl-4-methoxycatecholato)triphenylantimony(V) (Ph3Sb[(MeO)Cat], 3), its methanol solvate 3CH3OH (4); (3,6-di-tert-butyl-4,5-di-methoxycatecholato)triphenylantimony(V) (Ph3Sb[(MeO)2Cat], 5) and its acetonitrile solvate 5CH3CN (6). Complexes 1-7 were synthesized by oxidative addition of the corresponding o-iminobenzoquinones or o-benzoquinones to Ph3Sb. In the case of the phenanthrene-9,10-diolate (PhenCat) ligand, two different complexes were isolated: Ph3Sb[PhenCat] (7) and [Ph4Sb]+[Ph2Sb(PhenCat)2]- (8). Complexes 7 and 8 were found to be in equilibrium in solution. Molecular structures of 2, 4, 6, and 8 were determined by X-ray crystallography. Complexes 1-7 reversibly bind molecular oxygen to yield Ph3Sb[L-Me]O2 (9), Ph3Sb[L-iPr]O2 (10), Ph3Sb[(MeO)L']O2 (11), Ph3Sb[(MeO)2L']O2 (12) and Ph3Sb[PhenL']O2 (13), which contain five-membered trioxastibolane species (where L is the O,O',N-coordinated derivative of a 1-hydroperoxy-6-(N-aryl)-iminocyclohexa-2,4-dienol, and L' the O,O',O'-coordinated derivative of 6-hydroperoxy-6-hydroxycyclohexa-2,4-dienone). Complexes 9-13 were characterized by IR and 1H NMR spectroscopy and X-ray crystallography.     

Copper complexes of mono- and ditopic [(methylthio)methyl]borates: missing links and linked systems en route to copper enzyme models

TMEDA-free (TMEDA: tetramethylethylenediamine) LiCH(2)SMe is a suitable reagent for the selective introduction of (methylthio)methyl groups into PhBBr(2) and its p-silylated derivative Me(3)Si--C(6)H(4)--BBr(2). The resulting compounds, R*--C(6)H(4)--B(Br)(CH(2)SMe) (R*=H: 2; R*=SiMe(3): 7) and PhB(CH(2)SMe)(2) (3), form cyclic dimers through B--S adduct bonds in solution and in the solid state. Compounds 2 and 3 have successfully been used for preparing the (N(2)S) scorpionate [PhBpz(2)(CH(2)SMe)](-) ([5](-)) (pz: pyrazol-1-yl) and the (NS(2)) scorpionate [PhBpz(CH(2)SMe)(2)](-), respectively. Compound 7 proved to be an excellent building block for the heteroditopic poly(pyrazol-1-yl)borate p-[pz(3)B--C(6)H(4)--Bpz(2)(CH(2)SMe)](2-) ([10](2-)) that mimics the two ligation sites of the copper enzymes peptidylglycine alpha-hydroxylating monooxygenase and dopamine beta-monooxygenase. Treatment of the monotopic tripod [5](-) with CuCl and CuBr(2) results in the formation of complexes K[Cu(5)(2)] and [Cu(5)(2)]. An X-ray crystallography study of K[Cu(5)(2)] revealed a tetrahedral (N(2)S(2)) coordination environment for the Cu(I) ion, whereas the Cu(II) ion of [Cu(5)(2)] possesses a square-pyramidal (N(4)S) ligand sphere (S-atom in the axial position). The remarkable redox properties of K[Cu(5)(2)] and [Cu(5)(2)] have been assessed by cyclic voltammetry and quantum chemical calculations. The reaction of K[Cu(5)(2)] with dry air leads to the Cu(II) species [Cu(5)(2)] and to a tetranuclear Cu(II) complex featuring [PhB(O)pz(2)](2-) ligands. Addition of CuCl to K(2)[10] gives the complex K(3)[Cu(10)(2)] containing two ligand molecules per Cu(I) center. The Cu(I) ion binds to both heteroscorpionate moieties and thereby establishes a coordination environment similar to that of the Cu(I) ion in K[Cu(5)(2)].